Drug recall · April 22, 2020
Acetaminophen and Codeine Phosphate Tablets recall
Why: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/30 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ 08810, NDC 13107-059-99
- Lots / codes
Lot #: 059180023A, 059180024A and 059180025A, Exp. Date 05/2021
- Quantity
- 4332 units
- Company
- Aurobindo Pharma USA Inc., East Windsor, NJ
- Distribution
- Nationwide within the United States
- Initiated
- March 18, 2020 · Voluntary: Firm initiated
- Classified
- April 13, 2020
- Reported
- April 22, 2020
- Ended
- March 25, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Acetaminophen / codeine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.